Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Atherosclerosis

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.atherosclerosis.2015.02.014PMID 25733327PMCID PMC4527317
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A potent soluble epoxide hydrolase inhibitor, t-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes in vitro.

  2014cited by this paper
• Proprotein convertase subtilisin/kexin type 9 potentially influences cholesterol uptake in macrophages and reverse cholesterol transport

  2013cited by this paper
• Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates Diet-induced Endoplasmic Reticulum Stress in Liver and Adipose Tissue*

  2013cited by this paper
• Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.

  2012cited by this paper
• Inhibition of Soluble Epoxide Hydrolase Attenuates High-Fat-Diet–Induced Hepatic Steatosis by Reduced Systemic Inflammatory Status in Mice

  2012cited by this paper
• Adipose Modulation of High-Density Lipoprotein Cholesterol: Implications for Obesity, High-Density Lipoprotein Metabolism, and Cardiovascular Disease

  2011cited by this paper
• Adipose Tissue ATP Binding Cassette Transporter A1 Contributes to High-Density Lipoprotein Biogenesis In Vivo

  2011cited by this paper
• Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport[S]

  2011cited by this paper
• MiR-33 Contributes to the Regulation of Cholesterol Homeostasis

  2010cited by this paper
• Expression and Regulation of Soluble Epoxide Hydrolase in Adipose Tissue

  2010cited by this paper
• Inhibition or Deletion of Soluble Epoxide Hydrolase Prevents Hyperglycemia, Promotes Insulin Secretion, and Reduces Islet Apoptosis

  2010cited by this paper
• Adipocyte Modulation of High-Density Lipoprotein Cholesterol

  2010cited by this paper
• Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation

  2009cited by this paper
• Epoxyeicosatrienoic Acid Agonist Rescues the Metabolic Syndrome Phenotype of HO-2-Null Mice

  2009cited by this paper
• Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches.

  2009cited by this paper
• Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation and dyslipidemia in apolipoprotein E deficient mice infused with angiotensin II

  2009cited by this paper
• Specific Loss of Brain ABCA1 Increases Brain Cholesterol Uptake and Influences Neuronal Structure and Function

  2009cited by this paper
• Inflammation Impairs Reverse Cholesterol Transport In Vivo

  2009cited by this paper
• Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model

  2008cited by this paper
• Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice.

  2007cited by this paper
• Action of epoxyeicosatrienoic acids on cellular function.

  2007cited by this paper
• Goals of dyslipidemia management.

  2007cited by this paper
• Orally bioavailable potent soluble epoxide hydrolase inhibitors.

  2007cited by this paper
• Adipocytes as regulators of energy balance and glucose homeostasis

  2006cited by this paper
• Intestinal ABCA1 directly contributes to HDL biogenesis in vivo.

  2006cited by this paper
• Development of a high-throughput screen for soluble epoxide hydrolase inhibition.

  2006cited by this paper
• Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.

  2005cited by this paper
• Epoxide hydrolases: their roles and interactions with lipid metabolism.

  2005cited by this paper
• High-Density Lipoproteins Retard the Progression of Atherosclerosis and Favorably Remodel Lesions Without Suppressing Indices of Inflammation or Oxidation

  2004cited by this paper
• Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.

  2004cited by this paper
• Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred

  2004cited by this paper
• ATVB In Focus Role of ABCA1 in Cellular Cholesterol Efflux and Reverse Cholesterol Transport

  2003cited by this paper
• Importance of different pathways of cellular cholesterol efflux.

  2003cited by this paper
• Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

  2003cited by this paper
• Overexpression of Apolipoprotein A-I Promotes Reverse Transport of Cholesterol From Macrophages to Feces In Vivo

  2003cited by this paper
• ABCA1 mRNA and Protein Distribution Patterns Predict Multiple Different Roles and Levels of Regulation

  2002cited by this paper
• High-Dose Recombinant Apolipoprotein A-IMilano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E-Deficient Mice: Potential Implications for Acute Plaque Stabilization

  2001cited by this paper
• The evolving role of statins in the management of atherosclerosis.

  2000cited by this paper
• The ABCs of cholesterol efflux

  1999cited by this paper
• Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.

  1994cited by this paper
• Adipose tissue and cholesterol metabolism.

  1984cited by this paper

• Oxylipins in Atherosclerosis: Their Role in Inflammation, Diagnosis, and Therapeutic Perspectives

  2025cites this paper
• Endothelial soluble epoxide hydrolase links polyunsaturated fatty acid metabolism to oxidative stress and atherosclerosis progression

  2025cites this paper
• The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids

  2024cites this paper
• Aerobic exercise alleviates statin-induced PCSK9 upregulation by increasing epoxyeicosatrienoic acid levels through the FoxO3a–Sirt6 axis

  2024cites this paper
• A regulatory loop involving the cytochrome P450-soluble epoxide hydrolase axis and TGF-β signaling

  2024cites this paper
• CTRP1 decreases ABCA1 expression and promotes lipid accumulation through the miR‐424‐5p/FoxO1 pathway in THP‐1 macrophage‐derived foam cells

  2021cites this paper
• Soluble Epoxide Hydrolase Deletion Limits High-Fat Diet-Induced Inflammation

  2021cites this paper
• Changes in the Proteome Profile of People Achieving Remission of Type 2 Diabetes after Bariatric Surgery

  2021cites this paper
• Roles of Select Cytochrome P450 Epoxygenases in Brown Adipogenesis

  2021cites this paper
• Soluble epoxide hydrolase inhibitors improve angiogenic function of endothelial progenitor cells via ERK/p38-mediated miR-126 upregulation in myocardial infarction mice after exercise.

  2020cites this paper
• Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products.

  2020cites this paper
• Epoxy Fatty Acids Are Promising Targets for Treatment of Pain, Cardiovascular Disease and Other Indications Characterized by Mitochondrial Dysfunction, Endoplasmic Stress and Inflammation.

  2020cites this paper
• The phosphatase activity of soluble epoxide hydrolase regulates ATP‐binding cassette transporter‐A1‐dependent cholesterol efflux

  2019cites this paper
• Activation of Lipid Mediator Formation Due to Lipoprotein Apheresis

  2019cites this paper
• AUDA as a modulator of lipid profile and endothelial function in diet induced hypercholesterolemia in rats

  2019cites this paper
• Inhibition of Soluble Epoxide Hydrolase in Macrophages Ameliorates the Formation of Foam Cells　- Role of Heme Oxygenase-1.

  2019cites this paper
• Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment

  2019cites this paper
• Role of cytochrome P450-derived, polyunsaturated fatty acid mediators in diabetes and the metabolic syndrome.

  2019cites this paper
• Computer-Aided Selective Optimization of Side Activities of Talinolol.

  2019cites this paper
• Tumor-Induced Cholesterol Efflux from Macrophages Drives IL-4 Mediated Reprogramming and Tumor Progression

  2018cites this paper
• Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction

  2018cites this paper
• Role of sEH R287Q in LDLR expression, LDL binding to LDLR and LDL internalization in BEL-7402 cells.

  2018cites this paper
• EET Intervention on HO-1 Prevent Obesity Derived Cardiovascular Diseases

  2018cites this paper
• Cytochrome P450 2J2: Potential Role in Drug Metabolism and Cardiotoxicity

  2018cites this paper
• Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics

  2018cites this paper
• Stress, Genes, and Hypertension. Contribution of the ISIAH Rat Strain Study

  2018cites this paper
• Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine Danshen

  2018cites this paper
• Soluble epoxide hydrolase inhibitors, t-AUCB, regulated microRNA-1 and its target genes in myocardial infarction mice

  2017cites this paper
• Effects of Astaxanthin on Reverse Cholesterol Transport and Atherosclerosis in Mice

  2017cites this paper
• Soluble epoxide hydrolase inhibitors might prevent ischemic arrhythmias via microRNA-1 repression in primary neonatal mouse ventricular myocytes.

  2017cites this paper
• Soluble epoxide hydrolase (sEH) as a potential target for arterial hypertension therapy

  2017cites this paper
• Prenyl-flavonoids from Epimedium koreanum Nakai and their soluble epoxide hydrolase and tyrosinase inhibitory activities

  2017influential citation
• Soluble epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)-dodecanoic acid, represses human aortic smooth muscle cell proliferation and migration by regulating cell death pathways via the mTOR signaling.

  2017cites this paper
• linage recruitment and activity to promote inflammatory resolution and represent a novel internal regulatory system governing the establishment of adaptive immunity. Significance statement: A number of lipid mediators are known to contribute to inflammatory resolution. Fatty acid

  2016cites this paper
• Is sEHi lowering LDL-C by reducing expression of PCSK9 through SREBP2 pathway?

  2016cites this paper
• CYP450-derived oxylipins mediate inflammatory resolution

  2016cites this paper
• Soluble epoxide hydrolase: A potential target for metabolic diseases

  2016cites this paper
• Investigating cholesterol metabolism and ageing using a systems biology approach

  2016cites this paper
• A Mathematical Model of Atherosclerosis with Reverse Cholesterol Transport and Associated Risk Factors

  2014influential citation
• In Vitro Cell Culture Study of Anticholesterol and Antioxidant Activities of Myrmecodia platytyrae (MyP) Extract in WRL-68 Cells

  year unknowncites this paper